First Time Loading...

Provention Bio Inc
NASDAQ:PRVB

Watchlist Manager
Provention Bio Inc Logo
Provention Bio Inc
NASDAQ:PRVB
Watchlist
Price: 24.98 USD Market Closed
Updated: May 4, 2024

Intrinsic Value

PRVB's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. [ Read More ]

The intrinsic value of one PRVB stock under the Base Case scenario is 19.53 USD. Compared to the current market price of 24.98 USD, Provention Bio Inc is Overvalued by 22%.

Key Points:
PRVB Intrinsic Value
Base Case
19.53 USD
Overvaluation 22%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Provention Bio Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling PRVB stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Provention Bio Inc

Provide an overview of the primary business activities
of Provention Bio Inc.

What unique competitive advantages
does Provention Bio Inc hold over its rivals?

What risks and challenges
does Provention Bio Inc face in the near future?

Has there been any significant insider trading activity
in Provention Bio Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Provention Bio Inc.

Provide P/S
for Provention Bio Inc.

Provide P/E
for Provention Bio Inc.

Provide P/OCF
for Provention Bio Inc.

Provide P/FCFE
for Provention Bio Inc.

Provide P/B
for Provention Bio Inc.

Provide EV/S
for Provention Bio Inc.

Provide EV/GP
for Provention Bio Inc.

Provide EV/EBITDA
for Provention Bio Inc.

Provide EV/EBIT
for Provention Bio Inc.

Provide EV/OCF
for Provention Bio Inc.

Provide EV/FCFF
for Provention Bio Inc.

Provide EV/IC
for Provention Bio Inc.

Show me price targets
for Provention Bio Inc made by professional analysts.

What are the Revenue projections
for Provention Bio Inc?

How accurate were the past Revenue estimates
for Provention Bio Inc?

What are the Net Income projections
for Provention Bio Inc?

How accurate were the past Net Income estimates
for Provention Bio Inc?

What are the EPS projections
for Provention Bio Inc?

How accurate were the past EPS estimates
for Provention Bio Inc?

What are the EBIT projections
for Provention Bio Inc?

How accurate were the past EBIT estimates
for Provention Bio Inc?

Compare the revenue forecasts
for Provention Bio Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Provention Bio Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Provention Bio Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Provention Bio Inc compared to its peers.

Compare the P/E ratios
of Provention Bio Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Provention Bio Inc with its peers.

Analyze the financial leverage
of Provention Bio Inc compared to its main competitors.

Show all profitability ratios
for Provention Bio Inc.

Provide ROE
for Provention Bio Inc.

Provide ROA
for Provention Bio Inc.

Provide ROIC
for Provention Bio Inc.

Provide ROCE
for Provention Bio Inc.

Provide Gross Margin
for Provention Bio Inc.

Provide Operating Margin
for Provention Bio Inc.

Provide Net Margin
for Provention Bio Inc.

Provide FCF Margin
for Provention Bio Inc.

Show all solvency ratios
for Provention Bio Inc.

Provide D/E Ratio
for Provention Bio Inc.

Provide D/A Ratio
for Provention Bio Inc.

Provide Interest Coverage Ratio
for Provention Bio Inc.

Provide Altman Z-Score Ratio
for Provention Bio Inc.

Provide Quick Ratio
for Provention Bio Inc.

Provide Current Ratio
for Provention Bio Inc.

Provide Cash Ratio
for Provention Bio Inc.

What is the historical Revenue growth
over the last 5 years for Provention Bio Inc?

What is the historical Net Income growth
over the last 5 years for Provention Bio Inc?

What is the current Free Cash Flow
of Provention Bio Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Provention Bio Inc.

Financials

Balance Sheet Decomposition
Provention Bio Inc

Current Assets 174.6m
Cash & Short-Term Investments 165m
Receivables 1.4m
Other Current Assets 8.3m
Non-Current Assets 62.2m
PP&E 2.5m
Intangibles 59.6m
Other Non-Current Assets 120k
Current Liabilities 90.4m
Accounts Payable 6.8m
Accrued Liabilities 20.8m
Other Current Liabilities 62.9m
Non-Current Liabilities 24.6m
Long-Term Debt 23.5m
Other Non-Current Liabilities 1.1m
Efficiency

Earnings Waterfall
Provention Bio Inc

Revenue
12.9m USD
Cost of Revenue
-2.6m USD
Gross Profit
10.3m USD
Operating Expenses
-138.5m USD
Operating Income
-128.2m USD
Other Expenses
14.6m USD
Net Income
-113.6m USD

Free Cash Flow Analysis
Provention Bio Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

PRVB Profitability Score
Profitability Due Diligence

Provention Bio Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
Declining ROE
36/100
Profitability
Score

Provention Bio Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

PRVB Solvency Score
Solvency Due Diligence

Provention Bio Inc's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
47/100
Solvency
Score

Provention Bio Inc's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PRVB Price Targets Summary
Provention Bio Inc

There are no price targets for PRVB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

PRVB Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

PRVB Price
Provention Bio Inc

1M 1M
-
6M 6M
-
1Y 1Y
-
3Y 3Y
+246%
5Y 5Y
+531%
10Y 10Y
+419%
Annual Price Range
24.98
52w Low
N/A
52w High
N/A
Price Metrics
Average Annual Return 74.94%
Standard Deviation of Annual Returns 172.25%
Max Drawdown -27%
Shares Statistics
Market Capitalization 2.2B USD
Shares Outstanding 94 780 900
Percentage of Shares Shorted 7.58%

PRVB Return Decomposition
Main factors of price return

What is price return decomposition?

PRVB News

Last Important Events
Provention Bio Inc

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Provention Bio Inc

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Provention Bio Inc Logo
Provention Bio Inc

Country

United States of America

Industry

Pharmaceuticals

Market Cap

2.2B USD

Dividend Yield

0%

Description

Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. The company is headquartered in Red Bank New Jersey, New Jersey and currently employs 82 full-time employees. The company went IPO on 2018-07-24. The firm's product pipeline includes PRV-031 (teplizumab), PRV-3279, PRV-015 (ordesekimab) and PRV-101. Teplizumab is a humanized, anti-CD3 monoclonal antibody (mAb) for the delay of clinical type 1 diabetes (T1D) in at-risk individuals and for patients with newly diagnosed T1D. PRV-3279 is a humanized bispecific scaffold molecule targeting the B-cell surface proteins, CD32B and CD79B, for the treatment of systemic lupus erythematosus (SLE) and for the prevention of immunogenicity of biotherapeutics, such as those used in gene therapy. Ordesekimab is a human anti-interleukin 15 (IL-15) mAb for the treatment of gluten-free diet non-responsive celiac disease (NRCD). PRV-101 is a coxsackievirus B (CVB) vaccine to prevent acute CVB infections and, in those patients at-risk, to prevent the CVB-triggered autoimmune damage to pancreatic beta-cells.

Contact

NEW JERSEY
Red Bank New Jersey
55 Broad Street, 2Nd Floor
+19084289136.0
https://www.proventionbio.com/

IPO

2018-07-24

Employees

82

Officers

Co-Founder, Pres, CEO & Director
Mr. Ashleigh W. Palmer B.Sc., M.B.A.
Chief Financial Officer
Mr. Thierry Chauche
Chief Medical Officer
Dr. Eleanor L. Ramos M.D.
Co-Founder & Chief Scientific Officer
Dr. Francisco Leon M.D., Ph.D.
Chief Operations Officer
Ms. Christina Yi
VP of Investor Relations
Mr. Robert A. Doody Jr.
Show More
Chief Legal Officer
Ms. Heidy Abreu King-Jones J.D., L.L.M.
VP of Corp. Communications
Kaelan Hollon
VP Marketing
Mr. Jason Levine
Chief People Officer
Sarah O'Brien
Show Less

See Also

Discover More
What is the Intrinsic Value of one PRVB stock?

The intrinsic value of one PRVB stock under the Base Case scenario is 19.53 USD.

Is PRVB stock undervalued or overvalued?

Compared to the current market price of 24.98 USD, Provention Bio Inc is Overvalued by 22%.